The active conformation of human glucokinase is not altered by allosteric activators

被引:57
|
作者
Petit, Pierre [2 ]
Antoine, Mathias [1 ]
Ferry, Gilles [1 ]
Boutin, Jean A. [1 ]
Lagarde, Amandine
Gluais, Laure
Vincentelli, Renaud
Vuillard, Laurent [2 ]
机构
[1] Inst Rech Servier, F-78290 Croissy Sur Seine, France
[2] BioXtal, PX Unit, AFMB, UMR 6098, F-13288 Marseille 09, France
关键词
HUMAN PANCREATIC GLUCOKINASE; MOLECULAR REPLACEMENT; CRYSTAL-STRUCTURES; KINASE INHIBITORS; BINDING-SITES; GLUCOSE; ATP; HEPATOCYTES; MECHANISM; MUTATION;
D O I
10.1107/S0907444911036729
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Glucokinase (GK) catalyses the formation of glucose 6-phosphate from glucose and ATP. A specific feature of GK amongst hexokinases is that it can cycle between active and inactive conformations as a function of glucose concentration, resulting in a unique positive kinetic cooperativity with glucose, which turns GK into a unique key sensor of glucose metabolism, notably in the pancreas. GK is a target of antidiabetic drugs aimed at the activation of GK activity, leading to insulin secretion. Here, the first structures of a GK-glucose complex without activator, of GK-glucose-AMP-PNP and of GK-glucose-AMP-PNP with a bound activator are reported. All these structures are extremely similar, thus demonstrating that binding of GK activators does not result in conformational changes of the active protein but in stabilization of the active form of GK.
引用
收藏
页码:929 / 935
页数:7
相关论文
共 50 条
  • [1] Targeting human Glucokinase for the treatment of type 2 diabetes: an overview of allosteric Glucokinase activators
    Sharma, Prateek
    Singh, Sukhbir
    Sharma, Neelam
    Singla, Deepak
    Guarve, Kumar
    Grewal, Ajmer Singh
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2022, 21 (01) : 1129 - 1137
  • [2] Targeting human Glucokinase for the treatment of type 2 diabetes: an overview of allosteric Glucokinase activators
    Prateek Sharma
    Sukhbir Singh
    Neelam Sharma
    Deepak Singla
    Kumar Guarve
    Ajmer Singh Grewal
    Journal of Diabetes & Metabolic Disorders, 2022, 21 : 1129 - 1137
  • [3] Allosteric activators of glucokinase: Potential role in diabetes therapy
    Grimsby, J
    Sarabu, R
    Corbett, WL
    Haynes, NE
    Bizzarro, FT
    Coffey, JW
    Guertin, KR
    Hilliard, DW
    Kester, RF
    Mahaney, PE
    Marcus, L
    Qi, LD
    Spence, CL
    Tengi, J
    Magnuson, MA
    Chu, CA
    Dvorozniak, MT
    Matschinsky, FM
    Grippo, JF
    SCIENCE, 2003, 301 (5631) : 370 - 373
  • [4] Design, synthesis and biological evaluation of novel sulfamoyl benzamides as allosteric activators of human glucokinase
    Sharma, Prateek
    Goyal, Anju
    Grewal, Ajmer Singh
    CHEMICAL BIOLOGY LETTERS, 2024, 11 (01):
  • [5] Binding Kinetics of Glucose and Allosteric Activators to Human Glucokinase Reveal Multiple Conformational States
    Antoine, Mathias
    Boutin, Jean A.
    Ferry, Gilles
    BIOCHEMISTRY, 2009, 48 (23) : 5466 - 5482
  • [6] Discovery of potent and orally active 1,4-disubstituted indazoles as novel allosteric glucokinase activators
    Cheruvallath, Zacharia S.
    Gwaltney, Stephen L., II
    Sabat, Mark
    Tang, Mingnam
    Wang, Haixia
    Jennings, Andy
    Hosfield, David
    Lee, Bumsup
    Wu, Yiqin
    Halkowycz, Petro
    Grimshaw, Charles E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (12) : 2678 - 2682
  • [7] Discovery and hit-to-lead optimization of novel allosteric glucokinase activators
    Lang, Martin
    Seifert, Markus H. -J.
    Wolf, Kristina K.
    Aschenbrenner, Andrea
    Baumgartner, Roland
    Wieber, Tanja
    Trentinaglia, Viola
    Blisse, Marcus
    Tajima, Nobumitsu
    Yamashita, Tokuyuki
    Vitt, Daniel
    Noda, Hitoshi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (18) : 5417 - 5422
  • [8] Recent Developments in Medicinal Chemistry of Allosteric Activators of Human Glucokinase for Type 2 Diabetes Mellitus Therapeutics
    Grewal, Ajmer S.
    Lather, Viney
    Charaya, Neha
    Sharma, Neelam
    Singh, Sukhbir
    Kairys, Visvaldas
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (21) : 2510 - 2552
  • [9] Glucokinase activators
    Filipski, Kevin J.
    Futatsugi, Kentaro
    Pfefferkorn, Jeffrey A.
    Stevens, Benjamin D.
    PHARMACEUTICAL PATENT ANALYST, 2012, 1 (03) : 301 - 311
  • [10] Glucokinase activators
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (05) : 351 - 351